Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Descriptor ID |
D018357
|
MeSH Number(s) |
C02.782.580.600.620.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in this website by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 4 | 0 | 4 |
1996 | 3 | 1 | 4 |
1997 | 2 | 0 | 2 |
1998 | 3 | 1 | 4 |
1999 | 3 | 1 | 4 |
2000 | 6 | 4 | 10 |
2001 | 5 | 2 | 7 |
2002 | 3 | 0 | 3 |
2003 | 8 | 3 | 11 |
2004 | 4 | 2 | 6 |
2005 | 6 | 1 | 7 |
2006 | 2 | 3 | 5 |
2007 | 8 | 1 | 9 |
2008 | 2 | 0 | 2 |
2009 | 6 | 0 | 6 |
2010 | 9 | 1 | 10 |
2011 | 6 | 0 | 6 |
2012 | 7 | 1 | 8 |
2013 | 8 | 1 | 9 |
2014 | 12 | 3 | 15 |
2015 | 12 | 2 | 14 |
2016 | 11 | 2 | 13 |
2017 | 9 | 3 | 12 |
2018 | 11 | 2 | 13 |
2019 | 11 | 3 | 14 |
2020 | 10 | 1 | 11 |
2021 | 12 | 0 | 12 |
2022 | 6 | 0 | 6 |
2023 | 11 | 0 | 11 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Netw Open. 2024 Apr 01; 7(4):e244954.
-
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 07; 73(9):209-214.
-
Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020. Pediatrics. 2024 Mar 01; 153(3).
-
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 06; 72(40):1083-1088.
-
American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Transplant Cell Ther. 2023 Dec; 29(12):730-738.
-
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak. JAMA Netw Open. 2023 08 01; 6(8):e2328950.
-
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections. Virology. 2023 09; 586:115-121.
-
mRNA vaccines against respiratory viruses. Curr Opin Infect Dis. 2023 10 01; 36(5):385-393.
-
Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics. 2023 Jul 01; 152(1).
-
T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy. Br J Haematol. 2023 08; 202(4):874-878.